29 min. Read
5.12.23

The Big Health Report

In this article:

Big Health is a digital therapeutics company at an interesting inflection point: Should it pursue FDA clearance and a prescription pathway? E&O dug into this question and many others in this 7,500-word report. Read on for Big Health’s annual revenues, number of patients treated, pricing, performance guarantee, and much, much more.

Peter Hames, a business development exec working at a karaoke startup in London, wasn't the first insomniac sufferer who tried to convince Professor Colin Espie, a leading sleep disorders expert, to turn his book on Cognitive Behavioral Therapy into

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Approximating Omada Health’s S-1 Before Its 2025 IPO
11.22.24
21 min. Read
The Spring Health Report
8.18.23
20 min. Read
The Sword Health Report
8.02.23
21 min. Read
The Virta Health Report
10.28.22
31 min. Read
Who controls the Spice?
5.27.22
25 min. Read
The Noom Report
10.29.21
39 min. Read
The Crossover Health Report
4.19.21
22 min. Read
Analysis: Livongo founders’ HAAC SPAC
1.25.21
11 min. Read
The UnitedHealth Group Report
12.30.20
30 min. Read
The Virgin Pulse Report
9.25.20
14 min. Read
  • First
  • Previous
  • 1 of 2
  • Next
  • Last